The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

The CDC's vaccine advisory committee said it will study the childhood immunization schedule in the first meeting featuring HHS Secretary RFK Jr.'s hand-selected members.

Taking aim at a longtime target of anti-vaccine activists, CDC advisors said Thursday that the U.S. should not administer ...

GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults ...

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include adults ages 18 to 59 who are at high risk of severe illness if they ...

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year of age from respiratory syncytial virus during their first RSV season, the ...

The FDA has blessed Merck’s Enflonsia to prevent RSV in infants. The shot will challenge Sanofi and AstraZeneca’s blockbuster Beyfortus.

Brazilian state-controlled company Petrobras plans to contract an extra eight newbuild remotely operated vehicle support ...

The meeting included a discussion of thimerosal, a mercury-based preservative and longtime target of the anti-vaccine world.

The RSV led to her developing bronchiolitis once home, but the long term impact is still ongoing. Even now at 13-months-old, Winter is still on the road to a full recovery. “She still has a ...